SCHEMBL24927892

SCHEMBL24927892

CCC(C)C1(CN)NC(=O)NC1=O

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
GABRB3 P28472 1/20 0.37
OPRD1 P41143 1/20 0.37
GABRA2 P47869 1/20 0.37
GABRB2 P47870 1/20 0.37
POLB P06746 1/20 0.36
PKM P14618 1/20 0.36
LMNA P02545 1/20 0.33
ADAMTS5 Q9UNA0 3/20 0.33
ADAM17 P78536 1/20 0.33
MMP9 P14780 1/20 0.33
CYP19A1 P11511 1/20 0.31
MMP2 P08253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29873923 0.98 KDM4E (0.36) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL6690925 0.85 KDM4E (0.43) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL24938561 0.84 ADAMTS5 (0.34) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL23354823 0.82 ADAMTS5 (0.40) KDM4EALDH1A1CYP3A4GABRB3OPRD1
Hydrochloric Acid SCHEMBL23354793 0.82 ADAMTS5 (0.34) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL6694378 0.81 KDM4E (0.41) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL6692937 0.81 KDM4E (0.37) KDM4EALDH1A1CYP3A4GABRB3OPRD1
Hydrochloric Acid SCHEMBL31676880 0.81 ADAMTS5 (0.39) KDM4EALDH1A1CYP3A4GABRB3OPRD1
Hydrochloric Acid SCHEMBL23353975 0.81 ADAMTS5 (0.39) KDM4EALDH1A1CYP3A4GABRB3OPRD1
SCHEMBL6699914 0.79 KDM4E (0.39) KDM4EALDH1A1CYP3A4GABRB3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027985-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAMTS1 KDM4E 2923/4885ALDH1A1 2009/4885CYP3A4 3940/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 KDM4E 3062/4885ALDH1A1 3828/4885CYP3A4 3418/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.